-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million (+21%)
15 Oct 2024 18:00 CEST
Issuer
SPINEWAY
Press release
Ecully, October 15, 2024 – 6 p.m.
SPINEWAY
Continued organic growth
Nine-month 2024 revenue of €9.1 million (+21%)
| In thousands of euros | 2024 | 2023 | Change % |
| Q1 revenue | 3,070 | 2,398 | 28% |
| Q2 revenue | 3,465 | 3,033 | 14% |
| Q3 revenue | 2,575 | 2,077 | 24% |
| 9M revenue | 9,110 | 7,510 | 21% |
Unaudited consolidated data
The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an excellent third quarter in 2024, with revenue of €2.6 million, representing purely organic growth (excluding change in the scope of consolidation) of 24% compared with the previous year. As a result, nine-month revenue was €9.1 million, an increase of 21% on 2023.
This strong organic growth is being driven by accelerating sales of the new Distimp ranges, which will continue to be rolled out in Latin America in 2024. Nine-month revenue in the region totaled €3.2 million, up 42% on the same period last year.
In Europe, nine-month revenue came to €4.2 million (+14%), of which €2.3 million in France, which continued its good momentum with growth of 14% over the period. In Asia, revenue was €1.3 million, up 9% on 2023.
Spineway is moving ahead on its international registration program to take advantage of the many synergies between its products and its markets. Despite some administrative setbacks leading to delays in obtaining certain registrations, the Group confirms its solid revenue growth. In addition, the marketing initiatives and training sessions carried out in recent months in legacy markets should support the Group’s revenue growth.
Next event:
November 27, 2024 – 6 p.m. CET – Webinar – Business update
Register here
SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and more than 70% of its revenue comes from exports.
ISIN: FR001400BVK2 – ALSPW
Contacts:
SPINEWAY Shareholder-services line Available Tuesday through Thursday +33 (0)806 706 060 | AELIUM Investor relations Solène Kennis spineway@aelium.fr |
Attachment
Source
SPINEWAY
Provider
GlobeNewswire
Company Name
SPINEWAY
ISIN
FR001400N2P2
Symbol
ALSPW
Market
Euronext Growth